COMBINATION THERAPHY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE

• 收藏
• 分享

专利权人:

ROCHE GLYCART AG

发明人:

HERTING,FRANK,KLEIN,CHRISTIAN

申请号：

MYPI 2012000606

公开号：

MY163003A

申请日:

2010.08.12

申请国别(地区):

MY

年份:

2017

代理人:

摘要：

THE PRESENT INVENTION IS DIRECTED TO THE COMBINATION THERAPY OF AN AFUCOSYLATED ANTI-CD20 ANTIBODY WITH BENDAMUSTINE FOR THE TREATMENT OF CANCER, ESPECIALLY TO THE COMBINATION THERAPY OF CD20 EXPRESSING CANCERS WITH AN AFUCOSYLATED HUMANIZED B-LY1 ANTIBODY AND BENDAMUSTINE.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/